簡易懸濁時におけるACE阻害薬の安定性に対する酸化マグネシウムの影響

  • 高野 由博
    高崎健康福祉大学大学院薬学研究科臨床薬物動態学分野 つばさ薬局
  • 加部 春香
    高崎健康福祉大学薬学部生物薬剤学研究室
  • 溝井 健太
    高崎健康福祉大学薬学部生物薬剤学研究室
  • 箱田 恵子
    高崎健康福祉大学薬学部生物薬剤学研究室
  • 峯野 知子
    高崎健康福祉大学薬学部分子薬化学研究室
  • 矢野 健太郎
    横浜薬科大学薬学部薬物動態学研究室
  • 荻原 琢男
    高崎健康福祉大学大学院薬学研究科臨床薬物動態学分野 高崎健康福祉大学薬学部生物薬剤学研究室

書誌事項

タイトル別名
  • Effect of Magnesium Oxide on the Stability of ACE Inhibitors in Simple Suspension Method

この論文をさがす

抄録

<p>In the simple suspension method, the intended medicine is suspended in hot water when administered to a patient by tube. Suspension of the laxative, magnesium oxide is reported to hydrolyze ester-type drugs. Because several angiotensin converting enzyme (ACE) inhibitors have ester bonds in their structure, magnesium oxide may cause incompatibility when suspended with an ACE inhibitor. The purpose of this study was to clarify the effect of magnesium oxide on the stability of eight kinds of ACE inhibitors in the simple suspension method.</p><p>When suspended together with magnesium oxide in hot water (55℃), temocapril, delapril, captopril, and benazepril showed a significant decrease in concentration compared to when suspended alone. Enalapril, trandolapril, quinapril, and imidapril, however, showed no significant decrease. When temocapril was suspended with magnesium oxide, the concentration of its hydrolysis product temocaprilat was increased in a time-dependent manner. In addition, when temocapril was suspended in a carbonate-sodium bicarbonate buffer (pH 10.6), temocapril degradation was slower than with magnesium oxide, suggesting that the temocapril decomposition is not a simple hydrolysis caused only by pH but one requiring the presence of magnesium oxide as a catalyst.</p><p>Ester structures in ACE inhibitors are intended to improve gastrointestinal absorption. Therefore, the condition of several ACE inhibitors kept in suspension with magnesium oxide causes degradation of these drugs, inhibiting their absorption and pharmacological effects. It may be necessary for pharmacists to suggest to physicians that their prescriptions be changed to non-degradable ACE inhibitors and/or laxatives other than magnesium oxide.</p>

収録刊行物

  • 医療薬学

    医療薬学 47 (4), 208-216, 2021-04-10

    一般社団法人日本医療薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (13)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ